Cover Image
市場調查報告書

OncoTherapy Science, Inc. : 產品平台分析

OncoTherapy Science, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 199757
出版日期 內容資訊 英文 34 Pages
訂單完成後即時交付
價格
Back to Top
OncoTherapy Science, Inc. : 產品平台分析 OncoTherapy Science, Inc. - Product Pipeline Review - 2015
出版日期: 2015年09月16日 內容資訊: 英文 34 Pages
簡介

OncoTherapy Science, Inc.是開發抗體藥物的生物科技企業,提供臨床開發中的產品和抗癌藥,使用於各種癌症的治療。該公司還有雷射顯微解剖和互補DNA微陣列及標的遺傳基因的鑑定等技術平台。

本報告提供OncoTherapy Science, Inc.的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

OncoTherapy Science, Inc.的基本資料

  • ncoTherapy Science, Inc.概要
  • 主要資訊
  • 企業資料

OncoTherapy Science, Inc.:R&D概要

  • 主要的治療範圍

OncoTherapy Science, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

OncoTherapy Science, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
  • 開發階段不明的開發中產品
    • 開發階段不明的產品/聯合治療模式

OncoTherapy Science, Inc.:藥物簡介

OncoTherapy Science, Inc.:開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

OncoTherapy Science, Inc.:最近的開發平台趨勢

OncoTherapy Science, Inc.:暫停中的計劃

OncoTherapy Science, Inc.:總公司和子公司的所在地

  • 總公司
  • 其他據點及子公司

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07580CDB

Summary

Global Markets Direct's, 'OncoTherapy Science, Inc. - Product Pipeline Review - 2015', provides an overview of the OncoTherapy Science, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of OncoTherapy Science, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of OncoTherapy Science, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of OncoTherapy Science, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the OncoTherapy Science, Inc.'s pipeline products

Reasons to buy

  • Evaluate OncoTherapy Science, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of OncoTherapy Science, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the OncoTherapy Science, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of OncoTherapy Science, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of OncoTherapy Science, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of OncoTherapy Science, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • OncoTherapy Science, Inc. Snapshot
    • OncoTherapy Science, Inc. Overview
    • Key Information
    • Key Facts
  • OncoTherapy Science, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • OncoTherapy Science, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • OncoTherapy Science, Inc. - Pipeline Products Glance
    • OncoTherapy Science, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • OncoTherapy Science, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
    • OncoTherapy Science, Inc. - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • OncoTherapy Science, Inc. - Drug Profiles
    • elpamotide
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OCVC-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OTSGC-A24
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ONO-7268MX1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ONO-7268MX2
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OTS-167
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OTSA-101
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OTS-964
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • OncoTherapy Science, Inc. - Pipeline Analysis
    • OncoTherapy Science, Inc. - Pipeline Products by Target
    • OncoTherapy Science, Inc. - Pipeline Products by Route of Administration
    • OncoTherapy Science, Inc. - Pipeline Products by Molecule Type
    • OncoTherapy Science, Inc. - Pipeline Products by Mechanism of Action
  • OncoTherapy Science, Inc. - Recent Pipeline Updates
  • OncoTherapy Science, Inc. - Dormant Projects
  • OncoTherapy Science, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • OncoTherapy Science, Inc., Key Information
  • OncoTherapy Science, Inc., Key Facts
  • OncoTherapy Science, Inc. - Pipeline by Indication, 2015
  • OncoTherapy Science, Inc. - Pipeline by Stage of Development, 2015
  • OncoTherapy Science, Inc. - Monotherapy Products in Pipeline, 2015
  • OncoTherapy Science, Inc. - Out-Licensed Products in Pipeline, 2015
  • OncoTherapy Science, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • OncoTherapy Science, Inc. - Phase II, 2015
  • OncoTherapy Science, Inc. - Phase I, 2015
  • OncoTherapy Science, Inc. - Preclinical, 2015
  • OncoTherapy Science, Inc. - Unknown, 2015
  • OncoTherapy Science, Inc. - Pipeline by Target, 2015
  • OncoTherapy Science, Inc. - Pipeline by Route of Administration, 2015
  • OncoTherapy Science, Inc. - Pipeline by Molecule Type, 2015
  • OncoTherapy Science, Inc. - Pipeline Products by Mechanism of Action, 2015
  • OncoTherapy Science, Inc. - Recent Pipeline Updates, 2015
  • OncoTherapy Science, Inc. - Dormant Developmental Projects,2015
  • OncoTherapy Science, Inc., Subsidiaries

List of Figures

  • OncoTherapy Science, Inc. - Pipeline by Top 10 Indication, 2015
  • OncoTherapy Science, Inc. - Pipeline by Stage of Development, 2015
  • OncoTherapy Science, Inc. - Monotherapy Products in Pipeline, 2015
  • OncoTherapy Science, Inc. - Out-Licensed Products in Pipeline, 2015
  • OncoTherapy Science, Inc. - Pipeline by Top 10 Target, 2015
  • OncoTherapy Science, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • OncoTherapy Science, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • OncoTherapy Science, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top